Ankerstar Wealth’s Pfizer PFE Stock Holding History

Ankerstar Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$157K	Sell	6,506 -22	-0.3%	-$575	0.13%	82
2026 Q1	$183K	Buy	6,528 +2,308	+55%	+$61.4K	0.19%	69
2025 Q4	$105K	Buy	+4,220	New	+$106K	0.1%	99

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ankerstar Wealth's PFE Position: Q2 2026 in Review

Ankerstar Wealth reduced its Pfizer (PFE) stake by 0.34% in Q2 2026, selling an estimated $575 and leaving 6,506 shares worth $157K. The position accounts for 0.13% of the portfolio, ranked #82.

Ankerstar Wealth first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $183K in Q1 2026. 2,817 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Ankerstar Wealth held 6,506 shares of Pfizer worth $157K as of Q2 2026.
Ankerstar Wealth sold 22 Pfizer shares in Q2 2026, an estimated $575.
Pfizer made up 0.13% of Ankerstar Wealth's portfolio in Q2 2026, its #82 holding.
Ankerstar Wealth first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
Ankerstar Wealth's Pfizer position peaked at $183K in Q1 2026.
2,817 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ankerstar Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.